Highlights and Quick Summary
- Debt/Assets for the quarter ending December 31, 2022 was 5.75% (a 39.23% increase compared to previous quarter)
- Year-over-year quarterly Debt/Assets decreased by -33.22%
- Annual Debt/Assets for 2022 was 9.36% (a -31.08% decrease from previous year)
- Annual Debt/Assets for 2022 was 13.58% (a Infinity% increase from previous year)
- Annual Debt/Assets for 2021 was 0.0% (a -100.0% decrease from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Debt/Assets of Benitec Biopharma Limited
Most recent Debt/Assetsof BNTC including historical data for past 10 years.Interactive Chart of Debt/Assets of Benitec Biopharma Limited
Benitec Biopharma Limited Debt/Assets for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 5.75% | 4.13% | 13.58% | 8.61% | 9.36% |
| 2021 | 6.5% | 5.35% | 1.0% | 1.95% | 0.0% |
| 2020 | 2.0% | 4.03% | 1.84% | 0.0% | 1.84% |
| 2019 | – | – | 2.0% | 0.0% | 0.0% |
| 2018 | – | – | – | – | 0.0% |
| 2017 | – | – | – | 0.0% | 0.0% |
| 2016 | – | 0.0% | 0.0% | 0.0% | 0.0% |
| 2015 | – | – | 0.0% | 0.0% | 0.0% |
| 2014 | – | – | 0.0% | 0.0% | 0.0% |
| 2013 | 0.0% | – | – | – | 0.0% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology